Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-cell function in anti-GAD65(+)diabetes with residual beta-cell function.

Ryuji Suzuki1, Akira Shimada, Taro Maruyama

  • 1Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Journal of Autoimmunity
|February 27, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study.

Diabetes research and clinical practice·2026
Same author

Clinical Characteristics and Outcomes of Acute Megakaryoblastic Leukemia With t(1;22)(p13;q13) in Children.

Pediatric blood & cancer·2026
Same author

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Leukemia·2026
Same author

Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA study.

The journal of medical investigation : JMI·2026
Same author

Life-threatening acute complications persist among individuals with type 1 diabetes in Japan: A nationwide registry-based cross-sectional study.

Journal of diabetes investigation·2026
Same author

A Non-Fetal Chronic Residual Inflammatory Liver Phenotype After Transient Abnormal Myelopoiesis in Down Syndrome.

Pediatric blood & cancer·2026

Patients with high-titer anti-glutamic acid decarboxylase (GAD) 65 diabetes show distinct T-cell responses compared to low-titer patients. These differences in T-cell function, including lower interleukin-10 production and higher interferon-inducible protein-10, correlate with faster disease progression and insulin dependence.

Area of Science:

  • Immunology
  • Endocrinology
  • Diabetes Research

Background:

  • Anti-glutamic acid decarboxylase (GAD) 65 diabetes with residual beta-cell function presents varying clinical outcomes.
  • Patients with high-titer anti-GAD65 antibodies (>10U/ml) typically require insulin within 5 years, unlike low-titer (<1.3-9.9U/ml) patients who remain insulin-independent for over 15-20 years.

Purpose of the Study:

  • To investigate the differences in T-cell function between high-titer and low-titer anti-GAD65 diabetes groups.
  • To correlate T-cell responses with clinical outcomes, specifically the rate of insulin dependence.

Main Methods:

  • Analysis of T-cell function, including interleukin (IL)-10 production upon polyclonal activation.
  • Measurement of serum levels of interferon-inducible protein-10 (IP-10).

Related Experiment Videos

  • Detection and quantification of GAD65-reactive CD4(+) T-cells in peripheral blood.

    • Main Results:

    • High-titer group exhibited significantly lower IL-10 production compared to the low-titer group.
    • Serum IP-10 levels were significantly higher in the high-titer group.
    • A positive correlation between serum IP-10 and GAD65-reactive CD4(+) cells was observed exclusively in the high-titer group.

    Conclusions:

    • T-cell function significantly differs between high-titer and low-titer anti-GAD65 diabetes patients.
    • The combination of GAD65-reactive T-cells and elevated IP-10 may drive rapid disease progression in high-titer individuals.
    • These immunological differences support the observed disparities in clinical outcomes and insulin dependence.